Micrus reports on aneurysm trial for MicroCoil:
This article was originally published in Clinica
Executive Summary
Micrus has presented trial data on 120 intracranial aneurysms embolised using its minimally invasive ACT MicroCoil system. The product, which employs a heat resistive detachment system, was reported to be quick, effective and reliable in treating intracerebral aneurysms - principally wide neck lesions. The MicroCoil was used to treat patients with a wide variety of aneurysms and procedures done in both the anterior and posterior circulation of the brain were successful, said the Mountain View, California firm. The MicroCoil system gained US FDA and CE-mark approvals for sale last year.